Japan· JP-2149027F1012
マニジピン塩酸塩
A manidipine product containing マニジピン塩酸塩, registered in Japan, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Manidipine is registered in 5 of 19 countries.
Countries holding a registration under ATC C08CA11 (manidipine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 3 of them publish a price we can compare per daily dose
Manidipine · ATC C08CA11
5 / 19 countries
- Franceprice
- Italyprice
- Japan
- Spainprice
- United Kingdom
Price per daily dose
What a daily dose of manidipine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.17 in France to $0.29 in Spain — a ×1.7 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Manidipine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- ES Spain$0.29
- IT Italy$0.23
- FR France$0.17
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- マニジピン塩酸塩
- Manufacturer
- —
- Country
- Japan (JP)
- ATC code
- C08CA11
- ATC class
- Manidipine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for manidipine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Manidipine · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C08CA11
Manidipine, as other registers publish it.
- ItalyERREMANPHARMACARE S.R.L.
- ItalyIPERTENCHIESI FARMACEUTICI S.P.A.
- FranceIPERTEN 10 mg, compriméCHIESI
- United KingdomIperten 10mg tabletsImported (France)
- FranceIPERTEN 20 mg, compriméCHIESI
- United KingdomIperten 20mg tabletsImported (France)
- ItalyMANIDIPINA AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- ItalyMANIDIPINA DOC GENERICIDOC GENERICI S.R.L.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc4a8e00-267b-478a-ae61-bf796bfd301d GET /v1/drugs/cc4a8e00-267b-478a-ae61-bf796bfd301d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2149027F1012",
"category": "内用薬",
"price_yen": 10.8,
"generic_name": "マニジピン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2149",
"transitional_expiry": null
}See everything about manidipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.